Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice Patterns and Care Gaps in Lennox Gastaut Syndrome: A call for Action.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

TBC1D2B-related Neurodevelopmental Disorder with Gingival Overgrowth and Movement Disorders: A Case Series and Literature Review.

Journal of movement disorders·2026
Same author

Diagnosis and management guidelines for infantile epileptic spasms syndrome around the world: A scoping review and comparative study of international approaches.

Epilepsia·2026
Same author

Primary concomitant horizontal strabismus as a clinical biomarker of severity in West Syndrome.

Strabismus·2026
Same author

Navigating safety and sudden unexpected death in epilepsy (SUDEP) discussions in adolescents with epilepsy: short-term outcomes of a structured counselling intervention.

Epilepsy & behavior : E&B·2026
Same author

Education Research: Defining Competencies and Consensus in Canadian Epilepsy Fellowship Training: A Thematic Discourse Analysis of Expert Perspectives.

Neurology. Education·2026

Related Experiment Video

Updated: Jun 24, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.6K

Genetic Testing in Pediatric Epilepsy: Tools, Tips, and Navigating the Traps.

Sayoni Roy Chowdhury1, Robyn Whitney2, Rajesh RamachandranNair2

  • 1Department of Paediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, India.

Pediatric Neurology
|June 12, 2024
PubMed
Summary

Genetic testing is crucial for epilepsy diagnosis, with advanced sequencing techniques like exome or genome sequencing now recommended as first-tier tests. This review simplifies genetic testing approaches, counseling, and interpretation for better epilepsy management.

Keywords:
Developmental and epileptic encephalopathiesEpilepsyGenetic counselingMicroarrayNext-generation sequencing

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.6K

Related Experiment Videos

Last Updated: Jun 24, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.6K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.6K

Area of Science:

  • Genetics
  • Neurology
  • Clinical Diagnostics

Background:

  • Genetic testing is integral to modern epilepsy diagnosis and management.
  • Testing has evolved from gene panels to advanced sequencing techniques.
  • Genetic insights offer therapeutic, diagnostic, and prognostic benefits.

Purpose of the Study:

  • To simplify genetic testing in epilepsy.
  • To guide selection of appropriate genetic testing tools.
  • To address pre- and post-test counseling and interpretation of results.

Main Methods:

  • Narrative review of genetic testing modalities in epilepsy.
  • Analysis of clinical scenarios indicating genetic testing.
  • Discussion of strategies for inconclusive results.

Main Results:

  • High-throughput sequencing, particularly exome or genome sequencing, is increasingly recommended.
  • Specific epilepsy types (e.g., developmental and epileptic encephalopathies) have higher positive yields.
  • Comprehensive phenotyping and periodic reanalysis are key for inconclusive results.

Conclusions:

  • Exome or genome sequencing should be considered first-tier tests for epilepsy when feasible.
  • Effective genetic testing requires thorough clinical phenotyping and counseling.
  • Emerging genetic testing modalities will further advance epilepsy diagnosis and care.